Key result
Postoperative cognitive dysfunction occurs in 4% to 65% of surgical patients, driven by predictors like neuroinflammation and hypoxia, and may be mitigated by neuroprotective agents like dexmedetomidine.
Why the study?
The prevalence of postoperative cognitive dysfunction requires deeper study due to its impact on patient quality of life, hospital length of stay, and risk of severe complications and mortality.
Design
Literature review
Authors
Loading...
Variable POCD incidence warrants vigilance in postoperative care; leaves open standardized definitions and cardiac-specific prospective data.
This review highlights the high prevalence of postoperative cognitive dysfunction and discusses potential pharmacological strategies, including dexmedetomidine, for its prevention and management.
YAMSHCHIKOV et al. (2024) conducted a review in Postoperative cognitive dysfunction (POCD). Neuroprotective agents and anesthetic management (e.g., dexmedetomidine, cytoflavin) was evaluated. Postoperative cognitive dysfunction occurs in 4% to 65% of surgical patients, driven by predictors like neuroinflammation and hypoxia, and may be mitigated by neuroprotective agents like dexmedetomidine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: